Introduction

Abstract

This thesis is based on the following articles, referred to in the text by Roman numerals:

• I. Gasser, T. C., Larsen, E.H., Dörflinger, T., Madsen, P. O.: The influence of various body fluids and pH on E. coli MIC of quinolone derivatives. In: Weidner W (ed). Therapy of Prostatitis. Zuckschwerdt Verlag, München, 50–53,1986.

• II. Gasser, T. C., Graversen, P. H., Larsen, E. H., Dörflinger, T.: Quinolone penetration into canine vaginal and urethral secretions. Scand. J. Urol. Nephrol. 104 (suppl): 101–105, 1987.

• III. Gasser, T. C., Graversen, P. H., Madsen, P. O.: Fleroxacin (Ro 23–6240) distribution in canine prostatic tissue and fluids. Antimicrob. Agents Chemother. 31:1010–1013, 1987.

• IV. Gasser, T. C., Graversen, P. H., Larsen, E. H., Madsen, P. O.: Vergleichende Pharmakokinetik in der Prostata. In: Paul Ehrlich Gesellschaft (Naber KG, Adam D., Grobecker H., Hrsg.). Gyrase Hemmer II. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie. Futuramed Verlag, München, Band 6–10, 2027–2032, 1987.

• V. Gasser, T. C., Ebert, S. C., Graversen, P. H., Madsen, P. O.: Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrob. Agents Chemother. 31: 709–712, 1987.

• VI. Gasser, T. C., Graversen, P. H., Madsen, P. O.: Treatment of complicated urinary tract infections with ciprofloxacin. Am. J. Med. 82 (suppl 4A): 278–279, 1987.

• VII. Gasser, T. C., Madsen, P. O.: Antimicrobial prophylaxis in urology: Timing, dosing, and duration studies with special reference to high-risk conditions (unpublished).